Heritability of plasma amyloid β in typical late-onset Alzheimer's disease pedigrees

Genetic Epidemiology

Volumn 21, Issue 1, 2001, Pages 19-30

  Ertekin Taner, Nilufer ^a   Graff Radford, Neill ^a   Younkin, Linda H ^a   Eckman, Christopher ^a   Adamson, Jennifer ^a   Schaid, Daniel J ^b   Blangero, John ^c   Hutton, Michael ^a   Younkin, Steven G ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Heritability; Surrogate marker

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; DISEASE MARKER; GENE DOSAGE; GENE LOCUS; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; PEDIGREE; PHENOTYPE; QUANTITATIVE TRAIT;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHROMOSOME MAPPING; DOWN SYNDROME; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MODELS, GENETIC; MUTATION; PEDIGREE; PEPTIDE FRAGMENTS; PHENOTYPE; VARIATION (GENETICS);

EID: 0034936365     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/gepi.1015     Document Type: Article

References (37)

1. Multipoint quantitative-trait linkage analysis in general pedigrees
2. Human pedigree-based quantitative-trait-locus mapping: Localization of two genes influencing hdl-cholesterol metabolism
3. Robust inference for variance components models in families ascertained through probands: I. Conditioning on proband's phenotype
4. The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study
5. ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative
6. Sequential oligogenic linkage analysis routines (SOLAR) (Version 1.2.1)
7. Ascertainment and goodness of fit of variance component models for pedigree data
8. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo
9. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: The Cache County Study
10. The effect of nonrandom sampling on familial correlations
11. Quantitative trait locus for reading disability on chromosome 6
12. Linkage analysis of a common oligogenic disease using selected sib pairs
13. Linkage analysis of quantitative traits: Increased power by using selected samples
14. Non-random sampling in human genetics: Estimation of familial correlations, model testing, and interpretation
15. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production
16. Indication for linkage of the human OB gene region with extreme obesity
17. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2
18. Single-day apolipoprotein E genotyping
19. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
20. A new pathogenic mutation in the APP gene (I716V) increases the proportion of Aβ1-42(43)
21. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
22. Amyloid, the presenilins and Alzheimer's disease
23. The presenilins and Alzheimer's disease
24. Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression
25. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease
26. A full genome scan for late onset Alzheimer's disease
27. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels
28. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
29. Susceptibility locus for late onset Alzheimer's disease on chromosome 10
30. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study
31. Complete genomic screen in late-onset familial Alzheimer diseasek. Evidence for a new locus on chromosome 12
32. A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles
33. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
34. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants
35. Genetic factors in early- and late-onset Alzheimer's disease
36. Role of elevated amyloid β protein in patients with typical late onset Alzheimer's disease on chromosome 10